期刊文献+

特比萘芬体外抗丝状真菌药物敏感试验:菌体不同形态对MIC的影响 被引量:2

Effect of Hyphal and Conidial form on the in vitro Antifungal Susceptibility Testing of Some Filamentous Fungi to Terbinafine
原文传递
导出
摘要 目的观察特比萘芬对部分深部丝状真菌和皮肤癣菌的MIC及分别接种未发芽孢子、发芽孢子和菌丝对MIC的影响.方法参考M38-P(丝状真菌稀释法抗真菌药物敏感性试验参考方案)试验方案及其改进方案,测定特比萘芬对7株曲霉、5株着色真菌、4株波氏假阿利什霉、4株尖端赛多孢子菌及5株皮肤癣菌的未发芽孢子、发芽孢子或菌丝的MIC,并比较相互间的差异.结果受试菌株以未发芽孢子形态接种时,曲霉MIC范围为≤0.03~0.5 μg/mL,暗色真菌的MIC范围为≤0.03~0.06μg/mL,波氏假阿利什霉及尖端赛多孢子菌的MIC均>16 μg/mL,皮肤癣菌的MIC均≤0.03 μg/mL,提示上述菌株中除波氏假阿利什霉及尖端赛多孢子菌外,其余菌株体外均对特比萘芬敏感.所有受试菌中,除杂色曲霉和疣状瓶霉接种发芽孢子时MIC与接种菌丝时的MIC相差4倍外,其余菌株接种发芽孢子或菌丝悬液时的MIC与接种孢子时的MIC差异无显著性.结论受试曲霉、暗色真菌及皮肤癣菌体外均对特比萘芬敏感或较敏感.在丝状真菌的特比萘芬体外药物敏感试验中,接种易于获取并易于量化的未发芽孢子时的MIC可以反映特比萘芬体外对发芽孢子及菌丝的抗菌活性. Objective To compare the in vitro antifungal susceptibility of germinated, ungerminated conidia and hyphae of some filamentous fungi and dermatophytes to terbinafine. Methods The MICs of terbinafine for 7 isolates of Aspergillus spp., 5 isolates of dematiaceous fungi, 4 isolates of Pseudallescheria boydii, 4 isolates of Scedosporium apiospermum and 5 isolates of dermatophytes were examined using the NCCLS M38-P microdilution method. The isolates were inoculated in three different forms, ungerminated conidia, germinated conidia and hyphae respectively, in the tests. Results The MICs of terbinafine for the isolates of Aspergillus spp., dematiaceous fungi, Pseudallescheria boydii, Scedosporium apiospermum, and dermatophytes were ≤0.03 ~ 0.5 μg/mL, ≤0.03 ~ 0.06 μg/mL, > 16 μg/mL, > 16 μg/mL, and ≤0.03 μg/mL , respectively. The MICs did not show significant differences among the ungerminated conidia and the germinated conidia for all the isolates tested except A.versicolor and Phialophora verrucosa. Conclusions Terbinafine is effective against the isolates of Aspergillus spp., dematiaceous fungi and dermatophytes in vitro except Pseudallescheria boydii and Scedosporium apiospermum. The MIC of terbinafine obtained with ungerminated conidia may reflect the antifungal activity of terbinafine against germinated conidia and hyphae of some filamentous fungi in vitro.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2004年第8期452-454,共3页 Chinese Journal of Dermatology
关键词 特比萘芬 抗真菌药物 药物敏感试验 MIC 深部丝状真菌病 Antibiotics, antifungal Microbial sensitivity tests Fungi Hyphae Spores, fungal
  • 相关文献

参考文献9

  • 1Jessup CJ, Warner J, Isham N, et al. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidialgrowth and evaluation of susceptibility of clinical isolates. J Clin Microbiol, 2000, 38: 341-344.
  • 2Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol, 2000, 38: 155-159.
  • 3Ryder NS. Activity of terbinafine against serious fungal pathogens.Mycoses, 1999, 42 Suppl 2: 115-119.
  • 4McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol, 1998, 36:43-246.
  • 5Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol,1999, 37: 858-861.
  • 6Pujol I, Fernandez-Ballart J, Guarro J. Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp. J Antimicrob Chemother, 2001, 47: 715-718.
  • 7Guarro J, Llop C, Aguilar C, et al. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother, 1997, 41: 2760-2762. [8]Manavathu EK, Alangaden GJ, Lerner SA. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can J Microbiol, 1996, 42: 960-964.
  • 8Manavathu EK,Alangaden GJ,Lerner SA.A comparative study of the broth micro- and macro-dilution techniques for the determina-tion of the in uitro xusceptibility of Aspergillus fumigatus. Can J Microbiol,1996,42:960-964.anavathu EK, Alangaden GJ, Lerner SA. A comparative study of the broth micro- and macro-dilution techniques for the determina-tion of the in uitro xusceptibility of A spergillus fumigatus. Can JMicrobiol, 1996,42
  • 9李晋波,刘维达.特比萘芬对白念珠菌酵母相和菌丝相抗菌活性的比较[J].中华皮肤科杂志,2000,33(1):53-54. 被引量:21

二级参考文献1

  • 1郭宁如,现代真菌病诊断治疗学,1997年,51页

共引文献20

同被引文献14

  • 1苏晓红,车雅敏,连石,林俊萍,涂亚庭,张志华,乔福元,傅志宜.口服特比萘芬治疗生殖器念珠菌病多中心观察[J].中华皮肤科杂志,2004,37(8):497-497. 被引量:12
  • 2燕华玲,王爱平,万喆,李若瑜.特比萘芬对白念珠菌菌丝相和酵母相敏感性的比较[J].中华皮肤科杂志,2005,38(8):515-515. 被引量:9
  • 3黄烈,杨来智,林广城,陆学东.深部真菌的临床分布及药敏结果分析[J].现代检验医学杂志,2005,20(5):16-18. 被引量:11
  • 4张宏,杨敏,易敏,谢明.基于PCR-LIS-SSCP的白念珠菌菌丝相与酵母相ERG11基因比较研究[J].中华皮肤科杂志,2006,39(7):377-380. 被引量:2
  • 5Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol 1999;40:858 - 861.
  • 6Pujol I, Fernandez- Ballart J, Guarro J. Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus. spp. J Antimicrob Chemother 2001 ;47:715 - 718.
  • 7Guarro J, Llop C, Aguilar C, et al. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997;41:2760 - 2762.
  • 8Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741 - 745.
  • 9Meletiadis J, Meis JFGM, Mouton JW, et al. The EUROFUNG Network. In vitro activities of new and conventional antifungal agents againse clinical Scedosporium isolates. Antimicrob Agents Chemother 2002;46:62-68.
  • 10Nakai T, Uno J, Otomo K, et al. In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds. Chemotherapy 2002;48: 78 - 81.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部